Inventprise, a Redmond, Wash.–primarily based biotechnology firm creating vaccines for infectious illnesses, is shedding 76 employees, in keeping with a brand new submitting from the Washington Employment Safety Division.
GeekWire has reached out to the corporate for extra particulars.
The layoffs impression workers throughout the corporate’s Redmond and Woodinville services, in addition to some distant employees. The primary separations are efficient Dec. 31.
Job titles affected span a variety of roles, together with manufacturing, high quality management, R&D, and technical workers, in keeping with the submitting.
The corporate has almost 200 workers, in keeping with LinkedIn.
Based in 2012, Inventprise focuses on addressing international well being challenges in low- and middle-income international locations. Its pipeline contains lead candidate IVT-PCV-25, a pneumococcal conjugate vaccine candidate that’s in Part 2 trials, in keeping with the corporate’s web site.
Inventprise was based by Dr. Subhash Kapre, who beforehand labored on vaccine initiatives with the Gates Basis. The Seattle-based basis has provided greater than $13 million to Inventprise.
Kapre is presently chairman of Inventprise, which is led by CEO Yves Leurquin, a former Takeda exec who joined the corporate in 2021.
